SARA HANCOCK: Open Payments
NPI 1487351771 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,507 in 78 payments from 19 companies in 2025. Trend: 2023 $499 · 2024 $1,411 · 2025 $1,507
Food & beverage: $1,507
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $296 |
| ABBVIE INC. | 9 | $170 |
| Lundbeck LLC | 7 | $155 |
| Teva Pharmaceuticals USA, Inc. | 11 | $139 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Vanda Pharmaceuticals Inc. | 4 | $87 |
| Alkermes, Inc. | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $70 |
| Noven Therapeutics, LLC | 4 | $67 |
| Neurocrine BioSciences, Inc. | 3 | $60 |
Products named: REXULTI, VRAYLAR, ABILIFY ASIMTUFII, AUSTEDO XR, Auvelity, SPRAVATO, ARISTADA, Xelstrym.
Industry payments across KY — which companies pay providers there.
